1. MicroRNA-124 slows down the progression of Huntington′s disease by promoting neurogenesis in the striatum
- Author
-
Tian Liu, Wooseok Im, Inhee Mook-Jung, and Manho Kim
- Subjects
active zone stability ,Drosophila ,neuromuscular junction ,dephosphorylation ,Liprin-α ,Syd-1 ,PP2A ,GSK-3ß ,living scaffolds ,neural tissue engineering ,cell transplant ,biomaterials ,regeneration ,neurotrauma ,neurodegeneration ,axon pathfinding ,cell migration ,injury ,plasticity ,neurodegenerative disease ,brain ,therapy ,neuron ,microglia ,neural progenitor ,tissue engineering ,neuroregeneration ,repair ,central nervous system ,biomaterial ,regenerative medicine ,nanotechnology ,spinal cord injury ,axonal regeneration ,exosome ,extracellular vesicle ,microRNA ,microvesicle ,nerve gap ,neurite outgrowth ,peripheral nerve injury ,Schwann cell ,stem cell ,hemodynamic phases ,cerebral subarachnoid hemorrhage ,metabolic crises ,nerve regeneration ,hypoxic-ischemic brain damage ,ginsenoside Rg1 ,neural stem cells ,cell transplantation ,cell differentiation ,cognition ,nerve reconstruction ,neural regeneration ,brain injury ,neuroimaging ,functional magnetic resonance imaging ,regional homogeneity ,apoplexy ,subacute ,ischemia ,participants ,healthy ,volunteers ,brain activity ,NSFC grants ,neuroprotection ,cerebral ischemia/reperfusion injury ,lateral intracerebroventricular injection ,Apelin-13 ,nerve apoptosis ,Bcl-2 ,caspase-3 ,fractalkine ,CX3 chemokine receptor 1 ,neuronal maturation ,dendrites ,doublecortin ,synaptic maturation ,newborn neurons ,neurodegenerative diseases ,Alzheimer′s disease ,transgenic animal models ,mice ,epimedium herb ,milkvetch root ,kudzuvine root ,divalent metal transporter 1 ,ferroportin 1 ,microRNA-124 ,neurogenesis ,neuronal survival ,Huntington′s disease ,SRY-related HMG box transcription factor 9 ,brain-derived neurotrophic factor ,peroxisome proliferator-activated receptor gamma coactivator 1-alpha ,mutant huntingtin ,Neurology. Diseases of the nervous system ,RC346-429 - Abstract
MicroRNA-124 contributes to neurogenesis through regulating its targets, but its expression both in the brain of Huntington′s disease mouse models and patients is decreased. However, the effects of microRNA-124 on the progression of Huntington′s disease have not been reported. Results from this study showed that microRNA-124 increased the latency to fall for each R6/2 Huntington′s disease transgenic mouse in the rotarod test. 5-Bromo-2′-deoxyuridine (BrdU) staining of the striatum shows an increase in neurogenesis. In addition, brain-derived neurotrophic factor and peroxisome proliferator-activated receptor gamma coactivator 1-alpha protein levels in the striatum were increased and SRY-related HMG box transcription factor 9 protein level was decreased. These findings suggest that microRNA-124 slows down the progression of Huntington′s disease possibly through its important role in neuronal differentiation and survival.
- Published
- 2015
- Full Text
- View/download PDF